We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVAV icon
626
AeroVironment
AVAV
$7.57B
$321K ﹤0.01%
+4,488
New +$255K
LOXO
627
DELISTED
Loxo Oncology, Inc
LOXO
$320K ﹤0.01%
+1,847
New +$278K
HD icon
628
Home Depot
HD
$332B
$315K ﹤0.01%
+1,616
New +$302K
MRO
629
DELISTED
Marathon Oil Corporation
MRO
$315K ﹤0.01%
15,104
-1,287
-8% -$25.4K
IVW icon
630
iShares S&P 500 Growth ETF
IVW
$72.5B
$309K ﹤0.01%
+7,596
New +$305K
SCACU
631
DELISTED
Saban Capital Acquisition Corp. Units
SCACU
$300K ﹤0.01%
300,000
ARNA
632
DELISTED
Arena Pharmaceuticals Inc
ARNA
$297K ﹤0.01%
6,816
+1,278
+23% +$54.9K
WMGI
633
DELISTED
Wright Medical Group Inc
WMGI
$297K ﹤0.01%
+11,448
New +$262K
CMA
634
DELISTED
Comerica
CMA
$290K ﹤0.01%
3,194
-1,373
-30% -$132K
PBYI icon
635
Puma Biotechnology
PBYI
$406M
$289K ﹤0.01%
+4,892
New +$284K
PCH
636
DELISTED
PotlatchDeltic
PCH
$289K ﹤0.01%
+5,681
New +$288K
FHN icon
637
First Horizon
FHN
$12.1B
$285K ﹤0.01%
+15,968
New +$300K
SOGO
638
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$285K ﹤0.01%
+24,921
New +$248K
DBRG icon
639
DigitalBridge
DBRG
$2.94B
$272K ﹤0.01%
+10,898
New +$260K
IWF icon
640
iShares Russell 1000 Growth ETF
IWF
$122B
$272K ﹤0.01%
+7,556
New +$267K
CZR icon
641
Caesars Entertainment
CZR
$6.1B
$264K ﹤0.01%
6,752
-4,660
-41% -$193K
NVT icon
642
nVent Electric
NVT
$24.5B
$263K ﹤0.01%
+10,494
New +$273K
EWY icon
643
iShares MSCI South Korea ETF
EWY
$21.7B
$251K ﹤0.01%
+3,703
New +$270K
KOS icon
644
Kosmos Energy
KOS
$1.56B
$250K ﹤0.01%
+30,275
New +$221K
EPOL icon
645
iShares MSCI Poland ETF
EPOL
$669M
$244K ﹤0.01%
11,196
-14,927
-57% -$359K
HOLI
646
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$244K ﹤0.01%
+11,000
New +$258K
INDA icon
647
iShares MSCI India ETF
INDA
$6.71B
$243K ﹤0.01%
+7,300
New +$248K
FDC
648
DELISTED
First Data Corporation
FDC
$242K ﹤0.01%
+11,569
New +$214K
SCOR icon
649
Comscore
SCOR
$240K ﹤0.01%
+550
New +$259K
MZOR
650
DELISTED
Mazor Robotics Ltd.
MZOR
$240K ﹤0.01%
+4,315
New +$250K

Similar funds

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.